Skip to main content
SP5007,792.00+0.56%DOW53,767.41-0.01%NASDAQ26,783.06+0.73%BTC$63,148.00-0.37%ETH$1,876.65-0.50%GOLD$4,414.10-1.20%OIL$81.91-1.63%
Smart Investors Daily
Sign InSign Up Free
MT

NASDAQ · MTAC

MedTech Acquisition Corporation

Financial Services · Shell Companies

$11.34

Up+$1.78 (+18.67%)

Updated Aug 13, 2026, 6:10 PM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
83.86M
P/E ratio
-4.6
Dividend yield
0.00%
52-week range
— – —
Volume
176.27K
Avg. volume
2.73K

Price performance

MTAC price history

1M range · 0 trading sessions · Daily adjusted prices

MTAC does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest MTAC news

The latest Smart Investors Daily articles mentioning MTAC.

Stock researchCompany · Overview

MTAC research

Overview

Company profile and research snapshot.

Company profile

MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States.. The company was incorporated in 2020 and is based in Greenwich, Connecticut.

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

GlobeNewswire Inc. · Mar 10, 2022

MedTech Acquisition Corporation and Memic Innovative Surgery Ltd. Mutually Agree to Terminate Business Combination

TEL AVIV, Israel and FORT LAUDERDALE, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech”), a publicly traded special purpose acquisition company (SPAC) focused on medical technology, and Memic Innovative Surgery Ltd. (“Memic”), a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, today announced that both companies have mutually agreed to terminate, effective immediately, their previously announced business combination agreement dated August 12, 2021 due to market conditions and associated volatility as a result of recent world events.

Benzinga · Aug 13, 2021

Memic Going Public Via SPAC: What Investors Should Know About This Medical Device Company

A SPAC led by the founder of Memic Innovative Surgery and several experienced medical device company executives has announced its merger partner.  The SPAC Deal: Memic Innovative Surgery announced a SPAC merger with MedTech Acquisition Corp (NASDAQ: MTAC) Friday. The merger values Memic at $665 million. The deal is expected to close in the fourth quarter of 2021. About Memic: The Hominis platform from Memic is the first and only FDA authorized surgical robot featuring a miniature humanoid-shaped arm. ...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By